Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Links shared publicly online about this topic.
- 1,907total visits
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
View full resource at newsroom.lilly.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Alimta, Eli Lilly and Company
Most Recently Shared on July 10, 2009 at 5:45 pm By:
ALIMTA(R) (pemetrexed for injection) 1st Approval in EUas Maintenance Therapy for Adv Nonsquamous NSC Lung Cancer http://bit.ly/rwSmS
Advertisement
